Literature DB >> 20556394

[Internal medical investigations for non-arteritic retinal artery occlusion].

J Heinz1.   

Abstract

The causes of non-arteritic retinal artery occlusions rarely originate from the eye itself but are mostly the result of thrombo-embolic events which often develop due to atherosclerotic vascular changes, which in turn are often a consequence of internal diseases. In this article the most important internal medical examinations to identify related risk conditions are highlighted, which ensure that appropriate therapy can be initiated to reduce further possible vascular events. Additionally, a critical assessment is made concerning the implementation of thrombophilia diagnostics.

Entities:  

Mesh:

Year:  2010        PMID: 20556394     DOI: 10.1007/s00347-009-2112-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  35 in total

1.  [Impact of thrombophilic risk factors in patients with arterial thromboses].

Authors:  Rainer B Zotz
Journal:  Hamostaseologie       Date:  2008       Impact factor: 1.778

2.  Aggressive systematic treatment for central retinal artery occlusion.

Authors:  S Rumelt; Y Dorenboim; U Rehany
Journal:  Am J Ophthalmol       Date:  1999-12       Impact factor: 5.258

3.  Central retinal artery occlusion: visual outcome.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

Review 4.  Inherited thrombophilia in arterial disease: a selective review.

Authors:  Philippe de Moerloose; Françoise Boehlen
Journal:  Semin Hematol       Date:  2007-04       Impact factor: 3.851

5.  No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age.

Authors: 
Journal:  Circulation       Date:  2003-03-04       Impact factor: 29.690

6.  Low density lipoprotein triglycerides and lipoprotein(a) are risk factors for retinal vascular occlusion.

Authors:  Tatjana Stojakovic; Hubert Scharnagl; Winfried März; Bernhard R Winkelmann; Bernhard O Boehm; Otto Schmut
Journal:  Clin Chim Acta       Date:  2007-04-12       Impact factor: 3.786

7.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Authors:  James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

8.  Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis.

Authors:  Charles J Glueck; Ping Wang
Journal:  Clin Appl Thromb Hemost       Date:  2008-09-15       Impact factor: 2.389

Review 9.  The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature.

Authors:  A Girolami; M L Randi; S Gavasso; A M Lombardi; F Spiezia
Journal:  J Thromb Thrombolysis       Date:  2004-04       Impact factor: 2.300

10.  Vascular risk factors for central retinal artery occlusion.

Authors:  A K Rudkin; A W Lee; C S Chen
Journal:  Eye (Lond)       Date:  2009-06-12       Impact factor: 3.775

View more
  2 in total

Review 1.  [Retinal vascular diseases reflecting generalized vascular alterations. What can be mutually learnt?].

Authors:  N Feltgen; P Franko Zeitz
Journal:  Ophthalmologe       Date:  2014-01       Impact factor: 1.059

2.  [Ocular ischemic syndrome].

Authors:  A Pielen; B Junker; L Goldammer; M Schumacher; N Feltgen
Journal:  Ophthalmologe       Date:  2011-03       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.